BioSpace News Archive

The Feinstein Institutes for Medical Research, the science arm of Northwell Health, has named Lopa Mishra, MD, co-director for the Institute of Bioelectronic Medicine.

Covered employees will have access to $0 cost 24/7 virtual doctor visits, low cost prescription coverage, behavioral health support and Cigna’s networks of quality physicians, specialists and hospitals.

Cyclo Therapeutics, Inc. (Nasdaq: CYTH) (“Cyclo Therapeutics” or the “Company”), a clinical stage biotechnology company dedicated to developing life-changing medicines through science and innovation for patients and families suffering from diseases, today announced it will participate in the M-Vest Virtual Conference Series: Alzheimer’s Disease Panel on Wednesday, May 26, 2021 at 11:00 AM ET.

New facility expands access to innovative diagnostics and comprehensive laboratory services for Maryland, Virginia and D.C. veterinary teams

Subset Analysis of mCRPC Patients in PT-112-103-PAVE-1 Study Shows PT-112 in Combination with Avelumab is Well Tolerable with Anti-Tumor Effects

Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, today announced that John Houston, Ph.D., President and Chief Executive Officer and Ian Taylor, Ph.D., Chief Scientific Officer, will participate in a fireside chat at the UBS Global Healthcare Virtual Conference on Tuesday, May 25 at 10:00 a.m. ET.

Larimar Therapeutics, Inc. (“Larimar”) (Nasdaq: LRMR), a clinical-stage biotechnology company focused on developing treatments for Friedreich’s ataxia (FA) and other complex rare diseases, today announced that the European Medicines Agency (EMA) has granted Priority Medicines (PRIME) designation to CTI-1601 for the treatment of FA.

Luminex Corporation announced that its board of directors declared a cash dividend for the second quarter of 2021 of $0.10 per share of common stock payable on July 8, 2021 to stockholders of record as of the close of business June 17, 2021.

Zoetis held a virtual annual meeting today, with Chairman Michael B. McCallister presiding over the business portion of the meeting and shareholder voting. Chief Executive Officer Kristin Peck

National Health Investors, Inc. provided a business update regarding its monthly contractual cash collections.